and having listened to the conference
i am reminded that CB's baby is the Renal imaging and therapy.
he mentioned he would have liked to put it on its own in a separate company or something.
so i will not be surprised to see it surpass the success of Illuccix.
i do understand the market is apparently marginally smaller, but the Illuccix market was estimated at TAM $1B not so long ago
Renal imaging is also a monopoly
Prostate imaging just continues to grow. which is why i suspect both LNTH and TLX are growing well ATM
all boats are floating @!!
Ann: JP Morgan Healthcare Conference Presentation, page-47
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.73 |
Change
0.290(1.42%) |
Mkt cap ! $6.937B | |||
| Open | High | Low | Value | Volume |
| $20.57 | $20.73 | $20.16 | $20.61M | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 74 | $20.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.75 | 12799 | 5 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| TLX (ASX) Chart |